IHM
PFE icon

Iguana Healthcare Management’s Pfizer PFE Stock Holding History

Iguana Healthcare Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-421,600
Closed -$12.6M – 78
2015
Q3 		$12.6M Hold
421,600
– – 4.94% 3
2015
Q2 		$13.4M Buy
+421,600
New +$13.7M 4.23% 5
2014
Q4 		– Sell
-105,400
Closed -$2.96M – 68
2014
Q3 		$2.96M Buy
+105,400
New +$2.96M 1.58% 22

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Iguana Healthcare Management's PFE Position: Q1 2018 in Review

Iguana Healthcare Management sold out of Pfizer (PFE) in Q1 2018, closing a stake of 52,700 shares — an estimated $1.81M sold.

Iguana Healthcare Management first reported a position in PFE in Q1 2014 and held it in 10 quarters. The position peaked at $20.9M in Q1 2015. 2,230 funds tracked by Wall St. Rank hold PFE as of Q1 2018.

  • Iguana Healthcare Management reported no remaining Pfizer position as of Q1 2018 after selling out during the quarter.
  • Iguana Healthcare Management sold 52,700 Pfizer shares in Q1 2018, an estimated $1.81M.
  • Iguana Healthcare Management first reported a position in Pfizer in Q1 2014 and held it in 10 quarters.
  • Iguana Healthcare Management's Pfizer position peaked at $20.9M in Q1 2015.
  • 2,230 funds tracked by Wall St. Rank held Pfizer as of Q1 2018.

Based on Iguana Healthcare Management's 13F filing for Q1 2018, filed 15 May 2018.